Pharmaceutical care in smoking cessation
DOI:
https://doi.org/10.36560/19120262133Palavras-chave:
smoking cessation, nicotine dependence, FagerströmResumo
Smoking is one of the leading preventable causes of disease and death worldwide and is classified as a chronic disease due to nicotine dependence. In this context, pharmacists have proven to be essential professionals in smoking cessation efforts, working directly in primary care and public health programs. This study aimed to assess the degree of nicotine dependence among students at the Federal University of Mato Grosso (UFMT) – Sinop Campus, using the Fagerström Test, and to discuss the pharmacist’s role in this context. This is an investigative study approved by the Research Ethics Committee (Opinion No. 4.471.865/2020). The target population consisted of 136 students over 18 years of age, randomly selected. Data were collected through an electronic form containing demographic information and the Fagerström Test. The data were organized into tables and graphs and analyzed using Microsoft Excel. Most participants (70.6%) were between 18 and 24 years old. It was observed that 71.3% did not use any type of cigarette, and among smokers, 19.1% used electronic cigarettes. Nicotine dependence was classified as low to moderate in most cases, with only 2.9% of participants reporting smoking within the first five minutes after waking up — an indicator of high dependence. The analysis also showed that 1.5% reported difficulty giving up the first cigarette of the day, while 46.2% reported difficulty giving up any cigarette, suggesting a consolidated habit. The study demonstrated that the application of the Fagerström Test is a useful tool for identifying the degree of nicotine dependence, contributing to the development of effective intervention strategies. The pharmacist’s role is fundamental both in administering the test and in providing clinical, educational, and motivational support to patients. Their involvement in smoking cessation through counseling, pharmacotherapeutic follow-up, and participation in health campaigns is essential for the success of treatment and prevention of relapse, promoting significant improvements in quality of life and public health
Referências
BALBANI, A. P. S.; MONTOVANI, J. C. Métodos para abandono do tabagismo e tratamento da dependência da nicotina. Revista Brasileira de Otorrinolaringologia, São Paulo, v. 71, n. 6, p. 820–827, 2005.
BRASIL. Conselho Federal de Farmácia. Resolução CFF nº 585, de 29 de agosto de 2013. Regulamenta as atribuições clínicas do farmacêutico e dá outras providências. Disponível em: https://www.cff.org.br/userfiles/file/resolucoes/585.pdf. Acesso em: 8 abr. 2025.
BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas – Tabagismo. Brasília: Ministério da Saúde, 2020. Disponível em: https://linhasdecuidado.saude.gov.br/portal/tabagismo/atencao-especializada/planejamento-terapeutico. Acesso em: 8 abr. 2025.
BRASIL. Ministério da Saúde. Instituto Nacional de Câncer – INCA. Programa Nacional de Controle do Tabagismo – PNCT. Rio de Janeiro: INCA, 2023. Disponível em: https://www.inca.gov.br/programa-nacional-de-controle-do-tabagismo. Acesso em: 8 abr. 2025.
CARMO, J. T.; PUEYO, A. A. A adaptação ao português do Fagerström Test for Nicotine Dependence (FTND) para avaliar a dependência e tolerância à nicotina em fumantes brasileiros. Revista Brasileira de Medicina, v. 59, n. 1/2, p. 73–80, jan./fev. 2002.
GOULART, D. et al. Tabagismo em idosos. Revista Brasileira de Geriatria e Gerontologia, v. 13, p. 313–320, 2010.
INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA (INCA). Tabaco. Rio de Janeiro: INCA, 2022. Disponível em: https://www.inca.gov.br/assuntos/tabagismo. Acesso em: 10 maio 2025.
MENESES-GAYA, I. C. et al. As propriedades psicométricas do Teste de Fagerström para Dependência de Nicotina. Jornal Brasileiro de Pneumologia, v. 35, p. 73–82, 2009.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Scientific Electronic Archives
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
A revista se reserva o direito de fazer alterações nas regras originais, na ortografia e na ordem gramatical, a fim de manter o idioma de culto padrão, respeitando, no entanto, o estilo dos autores. Os artigos publicados são de propriedade da revista Scientific Electronic Archives, tornando-se sua reimpressão total ou parcial, sujeitos à autorização expressa da direção da revista. A fonte original da publicação deve ser mantida. Os originais não serão devolvidos aos autores. As opiniões expressas pelos autores dos artigos são de sua exclusiva responsabilidade.
The journal reserves the right to make changes to the original rules, spelling and grammatical order, in order to keep the language of worship default, respecting, however, the style of the authors. Articles published are the property of Scientific Electronic Archives magazine, becoming its total or partial reprint, subject to the express authorization of the direction of the journal. The original source of publication should be retained. The originals will not be returned to the authors. Opinions expressed by authors of articles are solely your responsibility.
This journal uses the License Creative Commons Atribuição 4.0 Internacional.
Accepted 2025-12-01
Published 2025-12-16
